CaldasCarlos Cancer Research UK, Cambridge Research InstituteUnited Kingdom

CaldasCarlos
Carlos Caldas is Professor of Cancer Medicine, University of Cambridge, and Head, Breast Cancer Functional Genomics Laboratory, Cancer Research UK Cambridge Institute. He is an Honorary Consultant Medical Oncologist and Breast Cancer Programme Director at the Cambridge Cancer Centre. He is Fellow of the Academy of the Medical Sciences, Fellow of the European Academy of Cancer Sciences, and EMBO Member. He received the 2016 ESMO Hamilton Fairley Award and holds an ERC Advanced Grant (2016-2021). He has published over 350 manuscripts, including in Nature, Cell, Cell Reports, New England Journal of Medicine, Nature Genetics, Nature Medicine, Science Translational Medicine and Nature Communications.

Thursday, 19 June 2025

Time Session
12:20
13:10
SamuelsYardena Chair Israel
  • ‘The EMBO Keynote Lecture’: Modelling breast cancers in space and time
    CaldasCarlos Keynote Speaker United Kingdom
  • EACR 2025 - Closing Remarks
    SamuelsYardena Chair Israel
Auditorium I

Wednesday, 18 June 2025

Time Session
11:35
13:10
CaldasCarlos Co-Chair United Kingdom
  • Epigenetic dysregulation and cancer evolution
    ScaffidiPaola Speaker Italy
  • Proffered Paper: Integrative multi-omic approach to identify patterns of immune selection in primary breast tumours
    EACR25-0508
    EACR25-0508
    MonterdeBeatriz Presenter United Kingdom
  • EMBO Young Investigator Lecture: Cancer aneuploidy - From evolutionary pressures to cellular vulnerabilities (REMOTE PRESENTATION)
    Ben-DavidUri Speaker Israel
  • Proffered Paper: Genetic background sets the trajectory of cancer evolution
    EACR25-2424
    EACR25-2424
    AitkenJSarah Presenter United States
  • Title to be announced
    TurajlicSamra Speaker United Kingdom
Auditorium I
15:20
16:55
CaldasCarlos Co-Chair United Kingdom
JacquemetGuillaume Co-Chair Finland
  • Agent-Based Modelling of Gene Networks the tumour microenvironment ecosytem
    BuffaMeteoraFrancesca Speaker United Kingdom
  • Proffered Paper: High-throughput drug screening in breast cancer PDTCs enables clinically relevant drug discovery for personalised medicine.
    EACR25-1681
    EACR25-1681
    MasinaRiccardo Presenter United Kingdom
  • The power of many: Unlocking treatment response patterns through single-cell meta-analysis (REMOTE PRESENTATION)
    AranDvir Speaker Israel
  • Proffered Paper: Spatial and multi-omic profiling of HGSC to identify immune vulnerabilities for precision immunotherapy
    EACR25-0439
    EACR25-0439
    ShabanovaAleksandra Presenter Finland
  • Harnessing computational tools to understanding somatic evolution in cancer
    McGranahanNicholas Speaker United Kingdom
Auditorium I